[1] |
WEI Manli, LYU Linyan, ZHENG Zhiyuan, YIN Jiye, MAI Zhixiong.
Preclinical genotoxicity evaluation of xueshuantong injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1014-1018.
|
[2] |
ZHENG Haiyun, ZHANG Wen, WANG Shaonan, ZHAO Haiyu, DU Shouying.
Anti-fatigue effects and mechanism of ginseng combined with caffeine in rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 863-870.
|
[3] |
ZHOU Xiuli, LIU Baosheng, MA Wenming, WANG Qi, WANG Yang, ZHAO Shipeng.
Clinical use of cinobufagin preparations in cancer patients
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 791-797.
|
[4] |
WEN Hairuo, HUANG Qin, HAN Suqin, JIANG Hua, QIN Chao, SHI Haokun, ZHAO Tingting, GENG Xingchao, WANG Qi.
Mutagenicity risk of N-nitrosobumetanil in SD rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 307-312.
|
[5] |
ZHANG Xiaoming, LYU Ping, HU Xinyue, DING Xiaoli, LI Jing, LIANG Chenggang.
Detection of single-chain precursor residues in insulin glargine by ELISA
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 290-294.
|
[6] |
HOU Jinfeng, LI Min, HUANG Xiaochun, KOU Jinping, CHE Baoquan, LIU Haitao, YAO Shangchen.
Determination of contents of erythromycin cyclocarbonate tablets using HPLC method
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1238-1242.
|
[7] |
HUANG Lu, LIU Bo, WANG Yan, FAN Huihong, ZHANG Qingsheng.
Research progress in quality control of nucleoside antiviral drugs
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 692-696.
|
[8] |
WEN Hairuo, WANG Yanan, JIANG Hua, WANG Xue, WANG Qi, MA Shuangcheng.
In vivo genotoxic risk assessment of emodin
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 635-640.
|
[9] |
WANG Yue, SONG Yujuan, LIU Qian, ZHAO Xiangmei, DENG Lijuan, FAN Huihong.
Quality evaluation and quality research of domestic hydroxyethyl starch 130/0.4 injection
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1067-1072.
|
[10] |
DUAN Xiying, WANG Dongyun, XU Jia, QIU Yajing, XU Mingzhe.
Determination of Silicon in Pantoprazole Sodium for Injection by ICP-MS
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 611-613.
|
[11] |
GAO Mei, MA Hui, CHEN Kai, ZHANG Daizhou.
Genotoxicity Evaluation of (R)-(+)-Rabeprazole Sodium for Injection
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 559-563.
|
[12] |
WANG Huiping, WANG Enli, XU Jiaoyan, YAO Jingchun.
Genetic Toxicity of Tongguan san
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(12): 861-866.
|
[13] |
LIU Zhao-hua, YAO Jing-chun, SUN Rong, GUO Yan-ru, ZENG Fan-guang.
Assessment of Immunosensitizing Potential of Shuanghuanglian for Injection Using Reporter Antigen Popliteal Lymph Node Assay
[J]. Chinese Journal of Pharmacovigilance, 2017, 14(1): 4-6.
|
[14] |
DENG Jian-hua,YANG Hong,WANG Fu-dong.
Study on the Preparation Process of Tazarotene Cream and Its Stability
[J]. Chinese Journal of Pharmacovigilance, 2016, 13(3): 146-147.
|
[15] |
WANG Yin-ying, LIU Cong-yan, ZHANG Wei, HE Jing-juan, SU Li, SUN Wan-ling.
Application of ATP Bioluminescence Assay in Chemosenstitivity of Acute Myeloid Leukemia Cells by ATP Bioluminescence in Vitro
[J]. Chinese Journal of Pharmacovigilance, 2016, 13(3): 132-137.
|